引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1938次   下载 138 本文二维码信息
码上扫一扫!
纳洛酮联合依达拉奉治疗急性缺血性脑卒中临床分析
何万福,陈群,贾进明
0
()
摘要:
目的:探讨纳洛酮联合依达拉奉在治疗急性缺血性脑卒中的应用效果。方法:80例病例选自2015年6月至2017年6月我院收治的急性缺血性脑卒中患者,将所选患者随机分为对照组和治疗组,每组患者各40例,对照组患者使用依达拉奉治疗,治疗组患者使用依达拉奉和纳洛酮联合治疗,分析两种治疗方法的临床疗效。结果:对照组、治疗组的有效率分别为75.0%,90.0%。结论:联合使用依达拉奉和纳洛酮治疗急性缺血性脑卒中,可提高治愈率,降低致残率和死亡率。
关键词:  
DOI:
基金项目:
Clinical analysis of Naloxone with Edaravone in the treatment of acute ischeminc stroke He Wanfu , Chen Qun , Jia Jinming
()
Abstract:
Objective To investigate the effect of Naloxone with Edaravone in the treatment of acute ischemic stroke.Method: choose 80 cases from June 2015 to June 2017, our hospital patients with acute ischemic stroke, the selected patients were randomly divided into treatment group and the control way, 40 cases in each group of patients, control group patients use in Edaravone in treatment, the treatment group patients with Edaravone and Naloxone combination therapy, analysis of the clinical efficacy of two treatment method. Results: the effective rate of control group was 75.0% and 90.0% respectively. Conclusion: combined with the treatment of acute ischemic stroke by Edaravone and Naloxone, the cure rate can be improved, the disability rate and death rate can be reduced
Key words:  

用微信扫一扫

用微信扫一扫